Bourlon, Maria T.
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
2 papers on CoChatORCID 0000-0002-3116-912X
Most cited papers
- Verified
Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma
Choueiri, T. K., Powles, T., Burotto, M., Escudier, B., Bourlon, M. T., Zurawski, B., Oyervides Juárez, V. M., Hsieh, J. J., Basso, U., Shah, A. Y., et al. (2021) · New England Journal of Medicine
Renal cell carcinoma treatmentCancer Immunotherapy and Biomarkers
Cited by 1,791
- Verified
Subcutaneous versus intravenous nivolumab for renal cell carcinoma
Albiges, L., Bourlon, M. T., Chacón, M., Cutuli, H. J., Chuken, Y. A. L., Żurawski, B., Mota, J. M., Magri, I., Burotto, M., Luz, M., et al. (2025) · Annals of Oncology
Renal cell carcinoma treatmentCancer Immunotherapy and Biomarkers
Cited by 31
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free